Insilico Medicine doses first patient in GENESIS-IPF-3, the world’s first phase III trial of a generative AI-driven innovative drug
Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers - EurekAlert!
Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC - EurekAlert!
Leukemia Breakthrough: Phase III Trial Achieves “Exceptional” Results
